Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate Hydrofluoroalkane (BDP HFA) Nasal Aerosol in Subjects 12 Years of Age and Older With SAR

The purpose of the study is to assess the efficacy and safety of an investigational nasal aerosol compared with placebo nasal aerosol in the treatment of seasonal allergic rhinitis.

Inclusion Criteria:

• Informed Consent
• Male or female subjects 12 years of age or older
• Documented history of season allergic rhinitis to mountain cedar pollen
• General good health
• Other criteria apply

Exclusion Criteria:

• History of physical findings of nasal pathology (within 60 days prior to screening visit)
• Participation in any investigational drug study 30 days preceding screening visit
• History of respiratory infection/disorder with 14 days preceding screening visit
• Use of any prohibited concomitant medications
• Other criteria apply